The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- 200,000 Cansino vaccines have arrived against the coronavirus: they will be applied to homeless people and refugees Sep 7, 2021
- The doctor told about the rules of sleep and weight loss in isolation Apr 20, 2020
- Covid vaccine 5-11 years, Ema: “In autumn the data” Sep 9, 2021
- Pyrénées-Orientales: A virtual place dedicated to diabetics created in the metaverse by the Perpignan hospital Nov 15, 2022
- Gilberto Rodríguez Orejuela, capo of the Cali cartel, died Jun 1, 2022
- Sexologist Zucchi (Santagostino): “Covid has remotely cleared the therapy” Sep 1, 2021
- Called the foods that trigger acne Aug 15, 2020